Lawrence Fitzgerald
Nessuna posizione attualmente
Profilo
Lawrence Fitzgerald worked as a Director & Head-Neuroscience Biology at AstraZeneca Pharmaceuticals LP, a Principal at Pfizer Inc., a Vice President at Lundbeck Research USA, Inc., a Principal at Pharmacia AB, and a Senior Scientist at DuPont Merck Pharmaceutical Co. He also worked as a Vice President-Biology at SAGE Therapeutics, Inc. from 2012 to 2013.
Fitzgerald received his undergraduate degree from Fairfield University, his MBA from the University of Michigan, and his graduate and doctorate degrees from Albany Medical College.
Precedenti posizioni note di Lawrence Fitzgerald
| Società | Posizione | Fine |
|---|---|---|
| Pharmacia AB | Corporate Officer/Principal | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Direttore/Membro del Consiglio | - |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Corporate Officer/Principal | - |
Formazione di Lawrence Fitzgerald
| Fairfield University | Undergraduate Degree |
| Albany Medical College | Doctorate Degree |
| University of Michigan | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Pharmacia AB | Health Technology |
- Borsa valori
- Insiders
- Lawrence Fitzgerald
